In summary, the DTX-loaded pH/ROS dual-responsive NPs achieved encouraging therapeutic efficacy and demonstrated great potential in preventing tumor metastasis, inhibiting tumor growth, and improving the efficacy of anti-PD-1 antibody. This evidence concerns the gene PDCD1 and neoplasm.